Three newer migraine drugs were included in the analysis: lasmiditan (Reyvow), rimegepant (Nurtec), and ubrogepant (Ubrelvy).

The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...

Parents pushed for years for treatments for the neuron disease Niemann-Pick type C. After setbacks, one drug now has FDA ...

Fentanyl-laced drugs are now the No. 1 killer of adults ages 18-45. Illicitly manufactured pills are laced with fentanyl and other poisons, pressed to resemble prescription drugs, and often sold ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6, when combined with ...

Paul DelPonte, executive director and CEO of the National Crime Prevention Council, likened this crisis to a Johnson & Johnson incident in 1982 when seven people died due to Tylenol ... who say their ...

The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...

A study from University of Iowa researchers investigates the impact of low-dose aspirin on blood pressure in older adults.

When given to children with ADHD ... for patients to take our medicines in accordance with U.S. Food and Drug Administration (FDA)-approved labeling guidance and in consultation with their ...

A pilot study showed that a small amount of ketamine can reduce or eliminate the withdrawal symptoms associated with quitting fentanyl.

Fentanyl overdoses have become a leading cause of death for minors over the last five years, even as drug use has dropped.

Fentanyl overdoses have become a leading cause of death for minors in the last five years or so — and social media, where ...